Title:
HISTONE DEACETYLASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2018/119362
Kind Code:
A8
Abstract:
Provided herein are compounds and methods for inhibiting histone deacetylase ("HDAC") enzymes (e.g., HDAC1, HDAC2, and HDAC3).
Inventors:
LUEDTKE GREGORY (US)
BHAGWAT SHRIPAD (US)
BHAGWAT SHRIPAD (US)
Application Number:
PCT/US2017/068118
Publication Date:
August 15, 2019
Filing Date:
December 22, 2017
Export Citation:
Assignee:
BIOMARIN PHARM INC (US)
International Classes:
C07D223/04; A61K31/397; A61K31/44; A61K31/4427; A61K31/4965; A61K31/55; A61K31/553; A61P25/00; C07D205/04; C07D211/12; C07D211/14; C07D241/04; C07D243/08; C07D487/10; C07D498/10
Attorney, Agent or Firm:
DANEK, Shelley, C. (US)
Download PDF:
Previous Patent: ELITE EVENT EE-GM4 AND METHODS AND KITS FOR IDENTIFYING SUCH EVENT IN BIOLOGICAL SAMPLES
Next Patent: HYBRID DISTRIBUTED COMMUNICATION
Next Patent: HYBRID DISTRIBUTED COMMUNICATION